|
|
|
Insider
Information: |
Cohen Chad M |
Relationship: |
Director |
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
56,286 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$131,826 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
56,286 |
|
|
Total
Value |
$131,826 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
44.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Zillow Group Inc |
Z |
CFO & Treasurer |
2015-02-18 |
183 |
2015-02-17 |
0 |
Premium* |
|
Trupanion Inc. |
TRUP |
Director |
2019-03-31 |
4,119 |
2018-03-31 |
0 |
Premium* |
|
Adaptive Biotechnologies Corp |
ADPT |
Chief Financial Officer |
2021-12-22 |
21,604 |
2019-07-01 |
0 |
Premium* |
|
Vacasa, Inc. |
VCSA |
Director |
2024-05-21 |
30,380 |
2022-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
110 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2020-12-08 |
4 |
OE |
$6.32 |
$189,600 |
D/D |
30,000 |
31,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2020-12-08 |
4 |
AS |
$50.88 |
$1,537,238 |
D/D |
(30,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-12 |
4 |
AS |
$62.25 |
$4,694,543 |
D/D |
(75,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-12 |
4 |
OE |
$6.32 |
$474,000 |
D/D |
75,000 |
76,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-13 |
4 |
OE |
$6.32 |
$316,000 |
D/D |
50,000 |
51,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-13 |
4 |
AS |
$62.92 |
$3,170,268 |
D/D |
(50,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-19 |
4 |
OE |
$6.32 |
$316,000 |
D/D |
50,000 |
51,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-19 |
4 |
AS |
$66.97 |
$3,430,421 |
D/D |
(50,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-20 |
4 |
AS |
$66.82 |
$3,366,555 |
D/D |
(50,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-20 |
4 |
OE |
$6.32 |
$316,000 |
D/D |
50,000 |
51,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-25 |
4 |
OE |
$6.32 |
$316,000 |
D/D |
50,000 |
51,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-25 |
4 |
AS |
$65.08 |
$3,303,382 |
D/D |
(50,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-26 |
4 |
OE |
$6.32 |
$316,000 |
D/D |
50,000 |
51,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-26 |
4 |
AS |
$62.71 |
$3,202,074 |
D/D |
(50,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-28 |
4 |
AS |
$55.04 |
$2,811,055 |
D/D |
(50,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-28 |
4 |
OE |
$6.32 |
$316,000 |
D/D |
50,000 |
51,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-29 |
4 |
OE |
$6.32 |
$316,000 |
D/D |
50,000 |
51,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-01-29 |
4 |
AS |
$55.77 |
$2,801,546 |
D/D |
(50,000) |
1,000 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,604 |
21,604 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-03-09 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
31,064 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-03-09 |
4 |
AS |
$40.02 |
$402,425 |
D/D |
(10,000) |
21,064 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-03-10 |
4 |
AS |
$42.54 |
$425,400 |
D/D |
(10,000) |
21,604 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-03-10 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
31,604 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-04-06 |
4 |
OE |
$6.32 |
$63,200 |
D/D |
10,000 |
31,604 |
0 |
- |
|
ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
|
2021-04-06 |
4 |
AS |
$40.95 |
$409,500 |
D/D |
(10,000) |
21,604 |
0 |
- |
|
110 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|